New drug combo shows promise for liver patients with bladder and breathing issues
NCT ID NCT07533565
First seen Apr 25, 2026 · Last updated Apr 25, 2026
Summary
This study tested the safety of two drugs, mirabegron and montelukast, in 78 adults with liver cirrhosis who also had overactive bladder and asthma. Researchers monitored bladder symptoms, breathing, and lab tests over three months. The goal was to see if these drugs could be used safely in this complex group of patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CIRRHOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kafr El-Sheikh University
Cairo, Kafr el-Sheikh Governorate, 33511, Egypt
Conditions
Explore the condition pages connected to this study.